| Product Code: ETC13137858 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Orexin Receptor Antagonists Market was valued at USD 0.6 Billion in 2024 and is expected to reach USD 1.2 Billion by 2031, growing at a compound annual growth rate of 10.30% during the forecast period (2025-2031).
The Global Orexin Receptor Antagonists Market is experiencing steady growth due to increasing prevalence of sleep disorders such as insomnia and narcolepsy, as well as rising awareness about the importance of proper sleep patterns for overall health. Orexin receptor antagonists are being increasingly used in the treatment of these conditions, driving market expansion. Additionally, ongoing research and development activities focused on expanding the therapeutic applications of orexin receptor antagonists are further propelling market growth. The market is also benefiting from strategic collaborations and partnerships between pharmaceutical companies to enhance product development and commercialization efforts. North America currently holds a significant market share, attributed to the high prevalence of sleep disorders in the region and the presence of key market players. Overall, the Global Orexin Receptor Antagonists Market is poised for continued growth in the coming years.
The Global Orexin Receptor Antagonists Market is witnessing growth due to the increasing prevalence of sleep disorders and the rising demand for effective treatment options. The market is driven by the development of novel orexin receptor antagonists with improved efficacy and safety profiles. Additionally, the growing awareness about the importance of sleep health and the expanding research activities in the field are creating opportunities for market expansion. The market is also benefiting from strategic collaborations between pharmaceutical companies to accelerate drug development and commercialization. Furthermore, the potential applications of orexin receptor antagonists in addressing other neurological disorders beyond sleep disorders are opening up new avenues for market growth. Overall, the Global Orexin Receptor Antagonists Market is poised for significant advancements and investments in the coming years.
In the Global Orexin Receptor Antagonists Market, challenges include limited awareness among healthcare providers and patients about orexin receptor antagonists, as well as the high cost of these medications which may restrict access for some individuals. Additionally, the regulatory approval process for new orexin receptor antagonists can be lengthy and complex, leading to delays in bringing innovative treatments to market. Competition from existing therapies and potential side effects associated with orexin receptor antagonists also pose challenges for market growth. Overall, market players in this segment need to focus on raising awareness, addressing pricing concerns, navigating regulatory hurdles, and demonstrating the value proposition of orexin receptor antagonists to overcome these challenges and drive market expansion.
The Global Orexin Receptor Antagonists Market is primarily driven by the increasing prevalence of sleep disorders such as narcolepsy and insomnia across the world. The rising awareness about the importance of sleep health and the growing demand for effective treatment options are also significant drivers. Additionally, advancements in drug development technologies and the increasing research and development activities in the field of orexin receptor antagonists are fueling market growth. Furthermore, the expanding geriatric population, who are more prone to sleep disorders, is contributing to the increased adoption of orexin receptor antagonists. The market is also being propelled by the potential benefits of these drugs in treating other conditions like obesity and addiction, driving further interest and investment in this therapeutic area.
Government policies related to the Global Orexin Receptor Antagonists Market typically focus on regulatory approval processes, intellectual property rights protection, and drug pricing regulations. Regulatory bodies such as the FDA in the United States and the EMA in Europe play a crucial role in approving orexin receptor antagonist drugs for market entry, ensuring their safety and efficacy. Additionally, governments may implement policies to incentivize research and development in this sector through grants, tax credits, or other funding mechanisms. Intellectual property rights protection is also essential to encourage innovation and investment in developing new orexin receptor antagonist therapies. Furthermore, governments may have regulations in place to control drug pricing to ensure affordability and access for patients, balancing the interests of pharmaceutical companies and healthcare systems.
The Global Orexin Receptor Antagonists Market is expected to witness significant growth in the coming years due to the increasing prevalence of sleep disorders such as narcolepsy and insomnia. The growing awareness about the importance of sleep hygiene and the rising demand for effective treatment options are driving the market expansion. Additionally, ongoing research and development activities aimed at developing novel orexin receptor antagonists with improved efficacy and safety profiles are projected to further boost market growth. The market is also likely to benefit from the expanding geriatric population and the increasing adoption of orexin receptor antagonists in both developed and developing regions. Overall, the Global Orexin Receptor Antagonists Market is anticipated to experience a steady increase in demand and revenue in the foreseeable future.
In the global orexin receptor antagonists market, Asia is expected to witness significant growth due to the increasing prevalence of sleep disorders and rising healthcare expenditure in countries like Japan and China. North America is anticipated to dominate the market, driven by the presence of key market players, high healthcare infrastructure, and growing awareness about sleep disorders. Europe is also expected to showcase substantial growth with the rising adoption of advanced therapeutics for sleep-related conditions. The Middle East and Africa region is likely to experience moderate growth, primarily due to improving healthcare facilities and increasing focus on sleep disorders management. Latin America is projected to witness steady growth, supported by the rising prevalence of sleep disorders and increasing healthcare investments in countries like Brazil and Mexico.
Global Orexin Receptor Antagonists Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Orexin Receptor Antagonists Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Orexin Receptor Antagonists Market Revenues & Volume, 2021 & 2031F |
3.3 Global Orexin Receptor Antagonists Market - Industry Life Cycle |
3.4 Global Orexin Receptor Antagonists Market - Porter's Five Forces |
3.5 Global Orexin Receptor Antagonists Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Orexin Receptor Antagonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.7 Global Orexin Receptor Antagonists Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Global Orexin Receptor Antagonists Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Orexin Receptor Antagonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Global Orexin Receptor Antagonists Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Orexin Receptor Antagonists Market Trends |
6 Global Orexin Receptor Antagonists Market, 2021 - 2031 |
6.1 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Orexin Receptor Antagonists Market, Revenues & Volume, By 5mg, 2021 - 2031 |
6.1.3 Global Orexin Receptor Antagonists Market, Revenues & Volume, By 10mg, 2021 - 2031 |
6.1.4 Global Orexin Receptor Antagonists Market, Revenues & Volume, By 15mg, 2021 - 2031 |
6.1.5 Global Orexin Receptor Antagonists Market, Revenues & Volume, By 20mg, 2021 - 2031 |
6.2 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Suvorexant, 2021 - 2031 |
6.2.3 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Lemborexant, 2021 - 2031 |
6.2.4 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Insomnia, 2021 - 2031 |
6.3.3 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Depression, 2021 - 2031 |
6.3.4 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Anxiety, 2021 - 2031 |
6.3.5 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Orexin Receptor Antagonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Speciality Centres, 2021 - 2031 |
6.4.5 Global Orexin Receptor Antagonists Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Orexin Receptor Antagonists Market, Overview & Analysis |
7.1 North America Orexin Receptor Antagonists Market Revenues & Volume, 2021 - 2031 |
7.2 North America Orexin Receptor Antagonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Orexin Receptor Antagonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
7.4 North America Orexin Receptor Antagonists Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.5 North America Orexin Receptor Antagonists Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Orexin Receptor Antagonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 Latin America (LATAM) Orexin Receptor Antagonists Market, Overview & Analysis |
8.1 Latin America (LATAM) Orexin Receptor Antagonists Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Orexin Receptor Antagonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Orexin Receptor Antagonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
8.4 Latin America (LATAM) Orexin Receptor Antagonists Market, Revenues & Volume, By Drugs, 2021 - 2031 |
8.5 Latin America (LATAM) Orexin Receptor Antagonists Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Orexin Receptor Antagonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9 Asia Orexin Receptor Antagonists Market, Overview & Analysis |
9.1 Asia Orexin Receptor Antagonists Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Orexin Receptor Antagonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Orexin Receptor Antagonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
9.4 Asia Orexin Receptor Antagonists Market, Revenues & Volume, By Drugs, 2021 - 2031 |
9.5 Asia Orexin Receptor Antagonists Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Orexin Receptor Antagonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10 Africa Orexin Receptor Antagonists Market, Overview & Analysis |
10.1 Africa Orexin Receptor Antagonists Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Orexin Receptor Antagonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Orexin Receptor Antagonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
10.4 Africa Orexin Receptor Antagonists Market, Revenues & Volume, By Drugs, 2021 - 2031 |
10.5 Africa Orexin Receptor Antagonists Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Orexin Receptor Antagonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11 Europe Orexin Receptor Antagonists Market, Overview & Analysis |
11.1 Europe Orexin Receptor Antagonists Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Orexin Receptor Antagonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Orexin Receptor Antagonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
11.4 Europe Orexin Receptor Antagonists Market, Revenues & Volume, By Drugs, 2021 - 2031 |
11.5 Europe Orexin Receptor Antagonists Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Orexin Receptor Antagonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12 Middle East Orexin Receptor Antagonists Market, Overview & Analysis |
12.1 Middle East Orexin Receptor Antagonists Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Orexin Receptor Antagonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Orexin Receptor Antagonists Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Orexin Receptor Antagonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
12.4 Middle East Orexin Receptor Antagonists Market, Revenues & Volume, By Drugs, 2021 - 2031 |
12.5 Middle East Orexin Receptor Antagonists Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Orexin Receptor Antagonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
13 Global Orexin Receptor Antagonists Market Key Performance Indicators |
14 Global Orexin Receptor Antagonists Market - Export/Import By Countries Assessment |
15 Global Orexin Receptor Antagonists Market - Opportunity Assessment |
15.1 Global Orexin Receptor Antagonists Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Orexin Receptor Antagonists Market Opportunity Assessment, By Dosage, 2021 & 2031F |
15.3 Global Orexin Receptor Antagonists Market Opportunity Assessment, By Drugs, 2021 & 2031F |
15.4 Global Orexin Receptor Antagonists Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Orexin Receptor Antagonists Market Opportunity Assessment, By End-Users, 2021 & 2031F |
16 Global Orexin Receptor Antagonists Market - Competitive Landscape |
16.1 Global Orexin Receptor Antagonists Market Revenue Share, By Companies, 2024 |
16.2 Global Orexin Receptor Antagonists Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |